tiprankstipranks
ZyVersa Therapeutics (ZVSA)
OTHER OTC:ZVSA
US Market
ZVSA
ZyVersa Therapeutics
RESEARCH TOOLSreports

ZyVersa Therapeutics (ZVSA) Income Statement

205 Followers

ZyVersa Therapeutics Income Statement

Last quarter (Q4 2025), ZyVersa Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, ZyVersa Therapeutics's net income was $-678.57M. See ZyVersa Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -6.93K$ -10.40K$ -10.40K$ -10.40K
Operating Expenses
$ 25.49M$ 9.13M$ 14.41M$ 13.82M$ 7.70M
Depreciation and Amortization
$ 0.00$ 6.93K$ 10.40K$ 10.40K$ 10.40K
EBITDA
$ -25.29M$ -9.14B$ -107.74M$ -14.43M$ -7.25M
Operating Income
$ -25.49B$ -9.14B$ -14.42M$ -13.83M$ -7.70M
Other Income/Expenses
$ 1.39B$ -283.35M$ -93.33M$ -1.03M$ -379.79K
Pretax Income
$ -24.10B$ -9.42B$ -107.75M$ -14.87M$ -8.08M
Net Income
$ -24.95B$ -9.41B$ -98.30M$ -14.05M$ -8.08M
Per Share Metrics
Basic EPS
$ -4.18$ -8.48$ -1.09K$ -930.25$ -173.66
Diluted EPS
$ -4.18$ -8.48$ -1.09K$ -930.25$ -173.66
Weighted Average Shares Outstanding
 5.96B 1.11M 97.50K 25.95K 46.55K
Weighted Average Shares Outstanding (Diluted)
 5.96B 1.11M 97.50K 25.95K 46.55K
Currency in USD

ZyVersa Therapeutics Earnings and Revenue History